Sage Therapeutics (SAGE) Stock Chart & Stock Price History $5.27 -0.08 (-1.50%) (As of 12/17/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Sage Therapeutics Stock Price Performance 5 Day Performance-2.14%1 Month Performance+10.25%3 Month Performance-30.57%6 Month Performance-50.98%Year-To-Date Performance-75.68%1 Year Performance-75.08% Receive SAGE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sage Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Secret Manhattan Project (Ad)On January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just spent six months investigating this...and what I found is shocking.Click here and I’ll show you exactly how to position your money SAGE Stock Chart for Wednesday, December, 18, 2024 SAGE Chart by TradingView Sage Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/17/2024$5.35$5.27-1.40%$5.48$5.071.17 million shs$322.38 million12/16/2024$5.39$5.35-0.74%$5.54$5.171.16 million shs$326.97 million12/13/2024$5.67$5.39-5.03%$5.72$5.031.74 million shs$329.40 million12/12/2024$5.89$5.67-3.74%$5.76$5.541.63 million shs$346.85 million12/11/2024$5.57$5.89+5.75%$5.91$5.51775,976 shs$360.29 million12/10/2024$5.56$5.57+0.18%$5.68$5.42913,761 shs$340.72 million Get the Latest News and Ratings for SAGE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sage Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/09/2024$5.61$5.56-0.89%$5.80$5.54804,920 shs$340.11 million12/06/2024$5.60$5.61+0.18%$5.81$5.50849,828 shs$343.16 million12/05/2024$5.61$5.60-0.18%$5.82$5.52850,308 shs$342.55 million12/04/2024$5.60$5.61+0.18%$5.79$5.58755,339 shs$343.18 million12/03/2024$5.79$5.60-3.28%$5.78$5.53672,750 shs$342.55 million12/02/2024$5.47$5.79+5.85%$5.83$5.45972,406 shs$354.17 million11/29/2024$5.55$5.47-1.44%$5.59$5.42329,870 shs$334.60 million11/28/2024$5.55$5.55$5.91$5.48581,359 shs$339.49 million11/27/2024$5.76$5.55-3.65%$5.91$5.48581,350 shs$339.49 million11/26/2024$5.28$5.76+9.09%$5.78$5.16724,934 shs$352.34 million11/25/2024$5.17$5.28+2.13%$5.48$5.19993,973 shs$322.98 million11/22/2024$4.85$5.17+6.60%$5.21$4.85870,886 shs$316.26 million11/21/2024$4.91$4.85-1.22%$5.19$4.801.49 million shs$296.67 million11/20/2024$4.91$4.91$5.13$4.621.59 million shs$300.35 million11/19/2024$4.78$4.91+2.72%$4.95$4.70931,277 shs$300.35 million11/18/2024$5.10$4.78-6.27%$5.09$4.74860,763 shs$292.41 million Related Companies Ardelyx Stock Chart Spyre Therapeutics Stock Chart Calliditas Therapeutics AB (publ) Stock Chart ARS Pharmaceuticals Stock Chart ANI Pharmaceuticals Stock Chart Syndax Pharmaceuticals Stock Chart Rocket Pharmaceuticals Stock Chart Bicycle Therapeutics Stock Chart Avadel Pharmaceuticals Stock Chart Collegium Pharmaceutical Stock Chart Receive SAGE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sage Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SAGE) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sage Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sage Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
